Impact Biomedical Inc. (IBO): Depreciation & Amortization
$1.15M
Year ended 2025-12-31
$1.14M
Trailing 12 months to 2026-06-30
+0.9%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.15M | +2.3% | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | $1.12M | -0.1% | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | $1.12M | +0.6% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $1.11M | n/a | 2024-02-20, From 2022-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.15M | +2.3% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $11.54M | -41.2% |
| Talphera, Inc. (TLPH) | 2024-12-31 | $0 | -100.0% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $20.2K | -1.0% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $1.04M | -12.0% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $344.0K | +103.6% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $704.0K | +6.7% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $246.0K | +138.8% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $173.0K | -12.2% |
Compare IBO, LYEL, TLPH, SKVI side by side · Screen every company in Pharmaceutical Preparations ↗